Vandetanib (Compound)

Synonyms:Vandetanib, 443913-73-3, Zactima, ZD6474, Caprelsa, N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine, vandetanib (zd6474), ZD-6474, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine, ZD 6474, GNF-PF-2188, ZD-64, AZD-6474, 338992-00-0, NSC-744325, NSC-760766, CHEMBL24828, N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine, YO460OQ37K, DTXSID1046681, CHEBI:49960, MFCD07772346, Vandetanib [INN], NCGC00167513-01, 4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazoline, N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine, DTXCID9026681, 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-yl)methoxyquinazoline, C22H24BrFN4O2, (4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(1-methyl-piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine, CAS-443913-73-3, UNII-YO460OQ37K, Vandetinib, HSDB 8198, 2ivu, Vandetanib [USAN:INN:BAN:JAN], Caprelsa (TN), Vandetanib- Bio-X, CH 331, CH-331, Vandetanib (Zactima), DMPC Cyclic Urea 1, Kinome_3316, VANDETANIB [MI], VANDETANIB [JAN], VANDETANIB [USAN], VANDETANIB [VANDF], BDBM21, SCHEMBL9044, VANDETANIB [MART.], VANDETANIB [WHO-DD], MLS006011672, Vandetanib (JAN/USAN/INN), AMY599, F9995-0087, GTPL5717, SCHEMBL21067679, VANDETANIB [ORANGE BOOK], cid_3081361, EX-A422, BCPP000023, HMS3244K03, HMS3244K04, HMS3244L03, HMS3654E11, HMS3672C07, BCP01925, Tox21_112511, 443913-73-3 (free base), NSC744325, NSC760766, NSC800961, s1046, AKOS015902350, Tox21_112511_1, AC-5251, CCG-269495, CS-0130, DB05294, NSC 744325, NSC 760766, NSC-800961, SB16919, 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline, N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine, NCGC00167513-02, NCGC00167513-03, NCGC00167513-04, NCGC00167513-09, 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE, 4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-, AS-11067, BV164508, HY-10260, SMR002530472, SY027438, FT-0656736, SW218092-2, EC-000.2359, A25648, D06407, EN300-265835, V-9402, AB01273969-01, AB01273969-02, AB01273969_04, SR-00000000462, Q7914515, SR-00000000462-2, BRD-K77625799-001-01-0, Z2512943095, 4-QUINAZOLINAMINE, N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYL-4- PIPERIDINYL)METHOXY)-, 6-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(5-carboxypentyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]hexanoic acid, Quinazolin-4-amine, N-(4-bromo-2-fluorophenyl)-6-mthoxy-7-[(1-methyl-4-piperidinyl)methoxy]-, Vandetanib;7-((4-aminocyclohexyl)methoxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine, ZD6

Id:3081361

Description:nan